NCT01605994View on ClinicalTrials.gov

Multiple Ascending-Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-933043 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Healthy Adult Normals
Interventions
DRUG

BMS-933043

DRUG

Placebo matching with BMS-933043

DRUG

Antacid Buffer Predose Solution

Trial Locations (1)

10019

Clinilabs, Inc., New York

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT01605994 - Multiple Ascending-Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-933043 in Healthy Subjects | Biotech Hunter | Biotech Hunter